Seroreversion in vertically HIV-1-infected children treated early and efficiently: Rule or exception?

AIDS

Volumn 24, Issue 17, 2010, Pages 2760-2761

  Eberle, Josef ^a   Notheis, Gundula ^a   Blattmann, Claudia ^b   Jung, Jutta ^a   Buchholz, Bernd ^c   Korn, Klaus ^d   Kulozik, Andreas E ^b   Schnitzler, Paul ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ZIDOVUDINE;

CASE REPORT; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; DRUG TREATMENT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; VERTICAL TRANSMISSION; VIREMIA; VIRUS LOAD;

ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 78349292243     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283405aab     Document Type: Letter

References (8)

1. Hare C, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, et al. Seroreversion in subjects receiving anti-retroviral therapy during acute/early HIV infection. Clin Infect Dis 2006; 42:700-708.
2. Amor A, Toro C, Jimenez V, Simon A, Ramos B, Soriano V. Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART. AIDS 2006; 20:1460 1462.
3. Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M, Sullivan JL, for the PACTG 356 investigators. Early therapy of vertical human immunodeficiency virus type (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol 2000; 47: 6984-6991.
4. Hainaut M, Peltier CA, Gerard M, Marissens D, Zissis G, Levy J. Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1. Eur J Pediatr 2000; 159:778-782.
5. Neubert J, Laws H-J, Adams O, Münk C, Krämer M, Niehues T, et al. HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immuno-deficiency syndrome. AIDS 2010; 24:327-330.
6. Markowitz M, Vesanen M, Tenner-Racz K, Cao Y, Binley JM, Talal A, et al. The effect of commencing combination antire-troviral therapy soon after human immunodeficiency type 1 infection on viral replication and antiviral immune responses. J Infect Dis 1999; 179:525-537.
7. Winchester R, Pitt J, Charurat M, Magder LS, Göring HH, Landay A, et al. Mother-to-child transmission of HIV-1: strong associa-tion with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr 2004; 36:659-670.
8. Blish CA, Blay WM, Haigwood NL, Overbaugh J. Transmissionof HIV-1 in the face of neutralizing antibodies. Curr HIV Res 2007; 5:578-587.